Medgenics intends to conduct public sale of common shares

Piper Jaffray is the bookrunner, has a 30-day, 15% greenshoe option

By Devika Patel

Knoxville, Tenn., Nov. 24 – Medgenics Inc. said it will price a public offering of common stock and warrants with a 30-day, 15% greenshoe option.

Piper Jaffray & Co is the bookrunner.

The medical technology and therapeutics company is based in San Francisco.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.